{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:28:22Z","timestamp":1773815302154,"version":"3.50.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e1 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024786","name":"Instituto Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Chagas disease (CD), caused by\n                      <jats:italic>Trypanosoma cruzi<\/jats:italic>\n                      , is a neglected tropical illness with significant public health impact, particularly due to its cardiac manifestations. Current etiological treatments, benznidazole and nifurtimox, are limited by prolonged administration, adverse effects, and low cure rates, especially in chronic cases. Natural products, such as cashew nut shell liquid (CNSL), are a promising source of bioactive compounds with trypanocidal and immunomodulatory properties, and the added benefit of low production costs, a valuable advantage in addressing neglected tropical diseases. LDT409, a synthetic saturated cardanol derivative from CNSL, was designed as a fatty acid mimetic and partial agonist of peroxisome proliferator-activated receptors (PPARs), nuclear transcription factors that regulate lipid metabolism and attenuate inflammation by modulating immune responses. In CD, PPARs regulate host\u2013parasite interactions by promoting anti-inflammatory immune polarization, which mitigates tissue-damaging inflammation but may also increase susceptibility to\n                      <jats:italic>T. cruzi<\/jats:italic>\n                      infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, we evaluated the trypanocidal activity and immunomodulatory effects of LDT409 using\n                      <jats:italic>in vitro<\/jats:italic>\n                      assays and an\n                      <jats:italic>in vivo<\/jats:italic>\n                      murine model of acute CD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our findings indicate that LDT409 treatment was associated with a reduction in peak parasitemia and with modulation of the host immune response, characterized by a shift toward a Th2\/Th17 profile and attenuation of a Th1-driven pro-inflammatory response, concomitant with reduced cardiac damage. Notably, the underlying mechanisms of these effects, including the involvement of PPARs, remain to be clarified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Together, these observations suggest that LDT409 may represent a promising, cost-effective, and sustainable compound for further investigation in the context of Chagas disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1749250","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:35:34Z","timestamp":1773812134000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the trypanocidal and immunomodulatory effects of LDT409, a cardanol derivative from cashew nut shell liquid"],"prefix":"10.3389","volume":"17","author":[{"given":"Juliana Magalh\u00e3es Chaves","family":"Barbosa","sequence":"first","affiliation":[{"name":"Laborat\u00f3rio de Biologia Celular, Instituto Oswaldo Cruz, Funda\u00e7\u00e3o Oswaldo Cruz","place":["Rio de Janeiro, RJ, Brazil"]},{"name":"Laborat\u00f3rio de Fisiopatologia Cl\u00ednica e Experimental, Instituto Oswaldo Cruz, Funda\u00e7\u00e3o Oswaldo Cruz","place":["Rio de Janeiro, RJ, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Pedra-Rezende","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Biologia Celular, Instituto Oswaldo Cruz, Funda\u00e7\u00e3o Oswaldo Cruz","place":["Rio de Janeiro, RJ, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Galv\u00e3o","family":"Melo","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Ultraestrutura Celular, Instituto Oswaldo Cruz, Funda\u00e7\u00e3o Oswaldo Cruz","place":["Rio de Janeiro, RJ, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Melo","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Biologia Celular, Instituto Oswaldo Cruz, Funda\u00e7\u00e3o Oswaldo Cruz","place":["Rio de Janeiro, RJ, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andressa Souza","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Desenvolvimento de Inova\u00e7\u00f5es Terap\u00eauticas, N\u00facleo de Medicina Tropical, Universidade de Bras\u00edlia","place":["Bras\u00edlia, DF, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat\u00e1lia Cipriano","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Desenvolvimento de Inova\u00e7\u00f5es Terap\u00eauticas, N\u00facleo de Medicina Tropical, Universidade de Bras\u00edlia","place":["Bras\u00edlia, DF, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Antonio Soares","family":"Romeiro","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Desenvolvimento de Inova\u00e7\u00f5es Terap\u00eauticas, N\u00facleo de Medicina Tropical, Universidade de Bras\u00edlia","place":["Bras\u00edlia, DF, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anissa","family":"Daliry","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Fisiopatologia Cl\u00ednica e Experimental, Instituto Oswaldo Cruz, Funda\u00e7\u00e3o Oswaldo Cruz","place":["Rio de Janeiro, RJ, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Salom\u00e3o","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Biologia Celular, Instituto Oswaldo Cruz, Funda\u00e7\u00e3o Oswaldo Cruz","place":["Rio de Janeiro, RJ, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e20230269","DOI":"10.36660\/abc.20230269","article-title":"SBC guideline on the diagnosis and treatment of patients with cardiomyopathy of chagas disease - 2023","volume":"120","author":"Marin-Neto","year":"2023","journal-title":"Arq Bras Cardiol"},{"key":"B2","unstructured":"Medell\u00edn (Colombia\n          FINAL REPORT\n          Chagas disease in the the Americas\n          \n          2023"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.2015.1103648","article-title":"Developments in the management of Chagas cardiomyopathy","volume":"13","author":"Tanowitz","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct1014204","article-title":"Antitrypanosomal therapy for chronic Chagas\u2019 disease","volume":"364","author":"Bern","year":"2011","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"112020","DOI":"10.1016\/j.biopha.2021.112020","article-title":"Advances in the treatment of Chagas disease: Promising new drugs, plants and targets","volume":"142","author":"Garc\u00eda-Huertas","year":"2021","journal-title":"BioMed Pharmacother Biomed Pharmacother"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1039\/D5NP00007F","article-title":"Natural products in antiparasitic drug discovery: advances, opportunities and challenges","volume":"42","author":"Shang","year":"2025","journal-title":"Nat Prod Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/0115680266256963230921061925","article-title":"Exploring the potential of natural products as antiparasitic agents for neglected tropical diseases","volume":"24","author":"Orosco","year":"2024","journal-title":"Curr Top Med Chem"},{"key":"B8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jep.2017.11.021","article-title":"Chemical characterization and pharmacological assessment of polysaccharide free, standardized cashew gum extract (Anacardium occidentale L.)","volume":"213","author":"da Silva","year":"2018","journal-title":"J Ethnopharmacol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-8741(98)00214-1","article-title":"Screening of some Nigerian medicinal plants for antibacterial activity","volume":"67","author":"Kudi","year":"1999","journal-title":"J Ethnopharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2010.08.003","article-title":"Antioxidant, larvicidal and antiacetylcholinesterase activities of cashew nut shell liquid constituents","volume":"117","author":"Oliveira","year":"2011","journal-title":"Acta Trop"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2011.00833.x","article-title":"Emerging roles of anacardic acid and its derivatives: a pharmacological overview","volume":"110","author":"Hemshekhar","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c01617","article-title":"Sustainable antiparasitic agents from an agro-industrial waste: mitochondria-targeting cashew nutshell liquid-derived phosphonium and ammonium salts","volume":"68","author":"Martinengo","year":"2025","journal-title":"J Med Chem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"105524","DOI":"10.1016\/j.tiv.2022.105524","article-title":"Antileishmania and immunomodulatory potential of cashew nut shell liquid and cardanol","volume":"87","author":"Ribeiro","year":"2023","journal-title":"Toxicol  Vitro"},{"key":"B14","volume-title":"Special issue on cashew nuts","author":"Csordas","year":"2021"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01542","article-title":"Phenolic lipids derived from cashew nut shell liquid to treat metabolic diseases","volume":"65","author":"Sahin","year":"2022","journal-title":"J Med Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2012.08.007","article-title":"PPAR\u03b3 ligand treatment inhibits cardiac inflammatory mediators induced by infection with different lethality strains of Trypanosoma cruzi","volume":"1832","author":"Penas","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.3c00076","article-title":"Valorizing Constituents of Cashew Nut Shell Liquid toward the Sustainable Development of New Drugs against Chagas Disease","volume":"9","author":"Nunes Lemes","year":"2023","journal-title":"ACS Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"112380","DOI":"10.1016\/j.mce.2024.112380","article-title":"LDT409 (pan-PPAR partial agonist) mitigates metabolic dysfunction-associated steatotic liver disease in high-fructose-fed mice","volume":"594","author":"Fernandes-da-Silva","year":"2024","journal-title":"Mol Cell Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s000110050622","article-title":"Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation","volume":"49","author":"Chinetti","year":"2000","journal-title":"Inflammation Res Off J Eur Histamine Res Soc Al"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762010000200005","article-title":"15d-PGJ2 modulates acute immune responses to Trypanosoma cruzi infection","volume":"105","author":"Rodrigues","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B21","doi-asserted-by":"publisher","first-page":"101958","DOI":"10.1016\/j.molmet.2024.101958","article-title":"A novel fatty acid mimetic with pan-PPAR partial agonist activity inhibits diet-induced obesity and metabolic dysfunction-associated steatotic liver disease","volume":"85","author":"Sahin","year":"2024","journal-title":"Mol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1538376","article-title":"Immune-endocrine crossroads: the impact of nuclear receptors in Tuberculosis and Chagas disease","volume":"16","author":"P\u00e9rez","year":"2025","journal-title":"Front Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e3181cdc398","article-title":"15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells","volume":"34","author":"Hovsepian","year":"2010","journal-title":"Shock Augusta Ga"},{"key":"B24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.bbadis.2014.12.019","article-title":"Treatment in vitro with PPAR\u03b1 and PPAR\u03b3 ligands drives M1-to-M2 polarization of macrophages from T","volume":"1852","author":"Penas","year":"2015","journal-title":"Cruzi-infected Mice Biochim Biophys Acta"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000491699","article-title":"Dysregulated network of immune, endocrine and metabolic markers is associated to more severe human chronic chagas cardiomyopathy","volume":"25","author":"Gonz\u00e1lez","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"B26","unstructured":"Neglected tropical diseases\n          \n          2025"},{"key":"B27","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease","volume":"81","author":"Filardi","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00210","article-title":"Precision health for chagas disease: integrating parasite and host factors to predict outcome of infection and response to therapy","volume":"10","author":"Martinez","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00979-18","article-title":"Repurposing Strategy of Atorvastatin against Trypanosoma cruzi: In Vitro Monotherapy and Combined Therapy with Benznidazole Exhibit Synergistic Trypanocidal Activity","volume":"62","author":"Araujo-Lima","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"B31","first-page":"198","article-title":"Interaction of Trypanosoma cruzi with heart muscle cells: ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis","volume":"41","author":"Meirelles","year":"1986","journal-title":"Vitro Eur J Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"110162","DOI":"10.1016\/j.biopha.2020.110162","article-title":"Synthesis and trypanocidal activity of novel pyridinyl-1,3,4-thiadiazole derivatives","volume":"127","author":"Freitas","year":"2020","journal-title":"BioMed Pharmacother Biomed Pharmacother"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0185221","DOI":"10.1128\/spectrum.01852-21","article-title":"Experimental combination therapy with amiodarone and low-dose benznidazole in a mouse model of trypanosoma cruzi acute infection","volume":"10","author":"Barbosa","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1645\/15-884","article-title":"Use of noninvasive parameters to evaluate swiss webster mice during trypanosoma cruzi experimental acute infection","volume":"102","author":"Campos","year":"2016","journal-title":"J Parasitol"},{"key":"B35","article-title":"Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi","volume":"4","author":"Brener","year":"1962","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.712034","article-title":"Physical exercise promotes a reduction in cardiac fibrosis in the chronic indeterminate form of experimental chagas disease","volume":"12","author":"Pedra-Rezende","year":"2021","journal-title":"Front Immunol"},{"key":"B37","first-page":"69","article-title":"Statistics corner: A guide to appropriate use of correlation coefficient in medical research","volume":"24","author":"Mukaka","year":"2012","journal-title":"Malawi Med J J Med Assoc Malawi"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e240057","DOI":"10.1590\/0074-02760240057","article-title":"Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models","volume":"119","author":"Soeiro","year":"2024","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0246811","DOI":"10.1371\/journal.pone.0246811","article-title":"Characterization and trypanocidal activity of a \u03b2-lapachone-containing drug carrier","volume":"16","author":"Barbosa","year":"2021","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"185918","DOI":"10.1093\/ecam\/nep014","article-title":"Brazilian green propolis: effects in vitro and in vivo on trypanosoma cruzi","volume":"2011","author":"Salom\u00e3o","year":"2011","journal-title":"Evid-Based Complement Altern Med ECAM"},{"key":"B41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1472-765X.2003.01458.x","article-title":"Chemical composition and microbicidal activity of extracts from Brazilian and Bulgarian propolis","volume":"38","author":"Salom\u00e3o","year":"2004","journal-title":"Lett Appl Microbiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-010-1988-6","article-title":"Croton cajucara crude extract and isolated terpenes: activity on Trypanosoma cruzi","volume":"107","author":"Campos","year":"2010","journal-title":"Parasitol Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201800790","article-title":"Discovery of sustainable drugs for neglected tropical diseases: cashew nut shell liquid (CNSL)-based hybrids target mitochondrial function and ATP production in trypanosoma brucei","volume":"14","author":"Cerone","year":"2019","journal-title":"ChemMedChem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"B45","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-16-0513","article-title":"Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones","volume":"234","author":"Geisler","year":"2017","journal-title":"J Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14735","article-title":"Effect of lipophilicity on drug distribution and elimination: Influence of obesity","volume":"87","author":"Bruno","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.306842","article-title":"Lipid use and misuse by the heart","volume":"118","author":"Schulze","year":"2016","journal-title":"Circ Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cytogfr.2021.10.001","article-title":"Chagas disease: Immunology of the disease at a glance","volume":"62","author":"Cristov\u00e3o-Silva","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e190389","DOI":"10.1590\/0074-02760190389","article-title":"Antiparasitic and anti-inflammatory activities of \u00df-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection","volume":"115","author":"Cascabulho","year":"2020","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1559494","article-title":"The NF-\u03baB signaling network in the life of T cells","volume":"16","author":"Daniels","year":"2025","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/me.2009-0374","article-title":"Minireview: Won\u2019t get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart","volume":"24","author":"Lockyer","year":"2010","journal-title":"Mol Endocrinol Baltim Md"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.9.4844","article-title":"15-Deoxy-delta12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway","volume":"97","author":"Straus","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-4758(99)01398-8","article-title":"Chagas disease etiology: autoimmunity or parasite persistence","volume":"15","author":"Tarleton","year":"1999","journal-title":"Parasitol Today Pers Ed"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/PL00008577","article-title":"IL-4 reduces resistance of mice to Trypanosoma cruzi infection","volume":"87","author":"Hiyama","year":"2001","journal-title":"Parasitol Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e604","DOI":"10.1371\/journal.pntd.0000604","article-title":"IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis","volume":"4","author":"da Matta Guedes","year":"2010","journal-title":"PloS Negl Trop Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0172833","DOI":"10.1371\/journal.pone.0172833","article-title":"The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular function","volume":"12","author":"Sousa","year":"2017","journal-title":"PloS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1749250\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:35:39Z","timestamp":1773812139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1749250\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2026.1749250"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1749250","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"article-number":"1749250"}}